Dornase alfa biosimilar (JHL Biotech)

阿法链道酶生物类似药（喜康生技）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDornase alfa biosimilar (JHL Biotech)

Drug Alias Name阿法链道酶生物仿制药（喜康生技）JHL-1922

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionDeoxyribonuclease 1 repalcementsDNA inhibitors

TargetsDNA

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesEden Biologics Inc

China Registration ClassN/A

Develop Information

Active CompaniesEden Biologics Inc

Inactive CompaniesJhl Biotech Usa Inc

Active IndicationsCystic Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeR05CB13